• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SOX4和SMARCA4通过转录激活TGFBR2协同调节PI3k信号通路。

SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2.

作者信息

Mehta Gaurav A, Angus Steven P, Khella Christen A, Tong Kevin, Khanna Pooja, Dixon Shelley A H, Verzi Michael P, Johnson Gary L, Gatza Michael L

机构信息

Department of Radiation Oncology, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

出版信息

NPJ Breast Cancer. 2021 Apr 9;7(1):40. doi: 10.1038/s41523-021-00248-2.

DOI:10.1038/s41523-021-00248-2
PMID:33837205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8035213/
Abstract

Dysregulation of PI3K/Akt signaling is a dominant feature in basal-like or triple-negative breast cancers (TNBC). However, the mechanisms regulating this pathway are largely unknown in this subset of aggressive tumors. Here we demonstrate that the transcription factor SOX4 is a key regulator of PI3K signaling in TNBC. Genomic and proteomic analyses coupled with mechanistic studies identified TGFBR2 as a direct transcriptional target of SOX4 and demonstrated that TGFBR2 is required to mediate SOX4-dependent PI3K signaling. We further report that SOX4 and the SWI/SNF ATPase SMARCA4, which are uniformly overexpressed in basal-like tumors, form a previously unreported complex that is required to maintain an open chromatin conformation at the TGFBR2 regulatory regions in order to mediate TGFBR2 expression and PI3K signaling. Collectively, our findings delineate the mechanism by which SOX4 and SMARCA4 cooperatively regulate PI3K/Akt signaling and suggest that this complex may play an essential role in TNBC genesis and/or progression.

摘要

PI3K/Akt信号通路失调是基底样或三阴性乳腺癌(TNBC)的一个主要特征。然而,在这类侵袭性肿瘤中,调节该信号通路的机制在很大程度上尚不清楚。在此,我们证明转录因子SOX4是TNBC中PI3K信号的关键调节因子。基因组和蛋白质组分析以及机制研究确定TGFBR2是SOX4的直接转录靶点,并证明TGFBR2是介导SOX4依赖性PI3K信号所必需的。我们进一步报道,在基底样肿瘤中均呈过表达的SOX4和SWI/SNF ATP酶SMARCA4形成了一种此前未报道的复合物,该复合物是维持TGFBR2调控区域开放染色质构象以介导TGFBR2表达和PI3K信号所必需的。总体而言,我们的研究结果阐明了SOX4和SMARCA4协同调节PI3K/Akt信号的机制,并表明该复合物可能在TNBC的发生和/或进展中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/110e39574e9e/41523_2021_248_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/0f1775b99e55/41523_2021_248_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/d9a646fecb32/41523_2021_248_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/8dc5cb9ccc68/41523_2021_248_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/230e55cc048a/41523_2021_248_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/26fd22349ca1/41523_2021_248_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/30fd0024261c/41523_2021_248_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/110e39574e9e/41523_2021_248_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/0f1775b99e55/41523_2021_248_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/d9a646fecb32/41523_2021_248_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/8dc5cb9ccc68/41523_2021_248_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/230e55cc048a/41523_2021_248_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/26fd22349ca1/41523_2021_248_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/30fd0024261c/41523_2021_248_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/8035213/110e39574e9e/41523_2021_248_Fig7_HTML.jpg

相似文献

1
SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2.SOX4和SMARCA4通过转录激活TGFBR2协同调节PI3k信号通路。
NPJ Breast Cancer. 2021 Apr 9;7(1):40. doi: 10.1038/s41523-021-00248-2.
2
SOX4-SMARCA4 complex promotes glycolysis-dependent TNBC cell growth through transcriptional regulation of Hexokinase 2.SOX4-SMARCA4复合物通过对己糖激酶2的转录调控促进糖酵解依赖性三阴性乳腺癌细胞生长。
bioRxiv. 2023 Sep 13:2023.09.10.557071. doi: 10.1101/2023.09.10.557071.
3
Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer.SOX4的扩增促进人类乳腺癌中的PI3K/Akt信号传导。
Breast Cancer Res Treat. 2017 Apr;162(3):439-450. doi: 10.1007/s10549-017-4139-2. Epub 2017 Feb 7.
4
LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway.富含亮氨酸重复序列蛋白 1(LEMD1)转录激活因子 SRY 相关高迁移率族盒蛋白 4(SOX4)通过上调磷脂酰肌醇 3-激酶(PI3K)/蛋白激酶 B(Akt)信号通路加速结肠癌细胞的进展。
Bioengineered. 2022 Apr;13(4):8087-8100. doi: 10.1080/21655979.2022.2047556.
5
TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets and .TGFB2-AS1 通过与 SMARCA4 相互作用并调控其靶基因抑制三阴性乳腺癌的进展。
Proc Natl Acad Sci U S A. 2022 Sep 27;119(39):e2117988119. doi: 10.1073/pnas.2117988119. Epub 2022 Sep 20.
6
MiR-296-3p inhibits cell proliferation by the SOX4-Wnt/βcatenin pathway in triple-negative breast cancer.miR-296-3p 通过 SOX4-Wnt/β-catenin 通路抑制三阴性乳腺癌细胞增殖。
J Biosci. 2021;46.
7
Long noncoding RNA-mediated activation of PROTOR1/PRR5-AKT signaling shunt downstream of PI3K in triple-negative breast cancer.长链非编码 RNA 介导的 PROTOR1/PRR5-AKT 信号激活在三阴性乳腺癌中绕过 PI3K 下游。
Proc Natl Acad Sci U S A. 2022 Oct 25;119(43):e2203180119. doi: 10.1073/pnas.2203180119. Epub 2022 Oct 21.
8
Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.Wnt信号通路阻断抑制三阴性乳腺癌细胞的增殖和迁移,并诱导其凋亡。
J Transl Med. 2013 Nov 4;11:280. doi: 10.1186/1479-5876-11-280.
9
SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation.SOX4对于由PTEN缺失引发的前列腺肿瘤发生至关重要。
Cancer Res. 2016 Mar 1;76(5):1112-21. doi: 10.1158/0008-5472.CAN-15-1868. Epub 2015 Dec 23.
10
SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition.SMARCA4 和其他 SWItch/Sucrose NonFermentable 家族基因改变在 NSCLC 中的临床病理特征和免疫检查点抑制的疗效。
J Thorac Oncol. 2021 Jul;16(7):1176-1187. doi: 10.1016/j.jtho.2021.03.024.

引用本文的文献

1
A novel SWI/SNF complex promotes triple-negative breast cancer progression.一种新型的SWI/SNF复合物促进三阴性乳腺癌进展。
Cell Mol Biol Lett. 2025 Sep 1;30(1):105. doi: 10.1186/s11658-025-00788-6.
2
SMARCA4 Inhibits Breast Cancer Progression and Metastasis through RHOA Suppression.SMARCA4通过抑制RHOA抑制乳腺癌进展和转移。
Cancer Res. 2025 May 15;85(10):1803-1818. doi: 10.1158/0008-5472.CAN-24-2801.
3
A cutting-edge investigation of the multifaceted role of SOX family genes in cancer pathogenesis through the modulation of various signaling pathways.

本文引用的文献

1
Combined targeting of G protein-coupled receptor and EGF receptor signaling overcomes resistance to PI3K pathway inhibitors in PTEN-null triple negative breast cancer.联合靶向 G 蛋白偶联受体和表皮生长因子受体信号通路克服了 PTEN 缺失型三阴性乳腺癌对 PI3K 通路抑制剂的耐药性。
EMBO Mol Med. 2020 Aug 7;12(8):e11987. doi: 10.15252/emmm.202011987. Epub 2020 Jul 16.
2
Quantitative Proteomics of the Cancer Cell Line Encyclopedia.癌症细胞系百科全书的定量蛋白质组学。
Cell. 2020 Jan 23;180(2):387-402.e16. doi: 10.1016/j.cell.2019.12.023.
3
Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.
一项通过调节多种信号通路对SOX家族基因在癌症发病机制中的多方面作用进行的前沿研究。
Funct Integr Genomics. 2025 Jan 4;25(1):6. doi: 10.1007/s10142-024-01517-6.
4
The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.SWI/SNF 复合物:癌症中经常发生突变的染色质重塑复合物。
Cancer Treat Res. 2023;190:211-244. doi: 10.1007/978-3-031-45654-1_7.
5
The ALKBH5/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathway.ALKBH5/SOX4轴通过激活SHH信号通路促进肝癌干细胞特性。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15499-15510. doi: 10.1007/s00432-023-05309-6. Epub 2023 Aug 30.
6
Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response.表观遗传修饰因子在乳腺癌发病机制和治疗反应中的新作用
Cancers (Basel). 2023 Aug 7;15(15):4005. doi: 10.3390/cancers15154005.
7
Delineation of a SMARCA4-specific competing endogenous RNA network and its function in hepatocellular carcinoma.SMARCA4特异性竞争性内源RNA网络的描绘及其在肝细胞癌中的作用。
World J Clin Cases. 2022 Oct 16;10(29):10501-10515. doi: 10.12998/wjcc.v10.i29.10501.
8
Identification of key genes involved in tamoxifen-resistant breast cancer using bioinformatics analysis.利用生物信息学分析鉴定他莫昔芬耐药乳腺癌相关关键基因
Transl Cancer Res. 2021 Dec;10(12):5246-5257. doi: 10.21037/tcr-21-1276.
9
Depletion Induces Cisplatin Resistance by Activating YAP1-Mediated Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer.在三阴性乳腺癌中,耗竭通过激活YAP1介导的上皮-间质转化诱导顺铂耐药。
Cancers (Basel). 2021 Oct 30;13(21):5474. doi: 10.3390/cancers13215474.
SOX 蛋白在乳腺癌发生和维持中的新作用。
J Mammary Gland Biol Neoplasia. 2019 Sep;24(3):213-230. doi: 10.1007/s10911-019-09430-6. Epub 2019 May 9.
4
Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis.全球转录分析鉴定出 SOX4 在肿瘤诱导血管生成中的新作用。
Elife. 2018 Dec 3;7:e27706. doi: 10.7554/eLife.27706.
5
SOX4 can redirect TGF-β-mediated SMAD3-transcriptional output in a context-dependent manner to promote tumorigenesis.SOX4 可以以依赖于上下文的方式重定向 TGF-β 介导的 SMAD3 转录产物,从而促进肿瘤发生。
Nucleic Acids Res. 2018 Oct 12;46(18):9578-9590. doi: 10.1093/nar/gky755.
6
High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.SMARCA4 或 SMARCA2 的高表达常与癌症的预后相反相关。
Sci Rep. 2018 Feb 1;8(1):2043. doi: 10.1038/s41598-018-20217-3.
7
Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.增强子转录揭示了控制乳腺癌发病机制的特定亚型基因表达程序。
Genome Res. 2018 Feb;28(2):159-170. doi: 10.1101/gr.226019.117. Epub 2017 Dec 22.
8
Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration.转化生长因子-β对乳腺癌细胞迁移中 Ephrin 型-A 受体 4 信号的调节。
Sci Rep. 2017 Nov 3;7(1):14976. doi: 10.1038/s41598-017-14549-9.
9
SOX4 Promotes Proliferative Signals by Regulating Glycolysis through AKT Activation in Melanoma Cells.SOX4通过激活AKT调控糖酵解促进黑色素瘤细胞的增殖信号。
J Invest Dermatol. 2017 Nov;137(11):2407-2416. doi: 10.1016/j.jid.2017.06.026. Epub 2017 Jul 29.
10
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.PI3K/AKT/mTOR信号通路改变的泛癌蛋白质基因组图谱
Cancer Cell. 2017 Jun 12;31(6):820-832.e3. doi: 10.1016/j.ccell.2017.04.013. Epub 2017 May 18.